Pacific Edge reported 22% revenue growth and continued investment in clinical evidence, while addressing Medicare coverage uncertainty and preparing for new product launches. The company remains focused on profitable markets and operational efficiency.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.